EUVIMEDEUVIMED entdecken
Fallbericht

A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A Mutation

Jonathan Q Trinh, Shristi Upadhyay Banskota, Alissa S Marr

ONCOLOGY · 2024

DOI: 10.46883/2024.25921022 ↗

Kurz gefasst

Fallbericht in der Zeitschrift ONCOLOGY, 2024. Verfasst von Jonathan Q Trinh und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mutation, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spiradenocarcinomas are rare malignant skin adnexal tumors. We describe a novel case of a patient with an aggressive CDKN2A-mutated spiradenocarcinoma who responded to a CDK4/6 inhibitor. This case highlights the unique nature of spiradenocarcinomas as well as the potential benefit of targeted therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutationCyclin-Dependent Kinase Inhibitor p16HumansCyclin-Dependent Kinase 4FemaleSkin NeoplasmsMiddle AgedAdenocarcinomaProtein Kinase InhibitorsCyclin-Dependent Kinase 6MalePyridinesSweat Gland NeoplasmsPiperazines

Substanzen

Cyclin-Dependent Kinase Inhibitor p16CDKN2A protein, humanCyclin-Dependent Kinase 4Protein Kinase InhibitorsCyclin-Dependent Kinase 6palbociclibPyridinesPiperazines

Zitieren

APA

Trinh, J. Q., Banskota, S. U., & Marr, A. S. (2024). A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A Mutation. ONCOLOGY. https://doi.org/10.46883/2024.25921022

Vancouver

Trinh JQ, Banskota SU, Marr AS. A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A Mutation. ONCOLOGY. 2024. doi:10.46883/2024.25921022

BibTeX
@article{Trinh2024,
  author = {Trinh, Jonathan Q and Banskota, Shristi Upadhyay and Marr, Alissa S},
  title = {A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A Mutation},
  journal = {ONCOLOGY},
  year = {2024},
  doi = {10.46883/2024.25921022}
}
Kostenlos starten →